| Citation: |
SHENG Yuping, MA Xiaoying, SUN Fuyun, YANG Xingmeng, WANG Na, ZHANG Haoran, XU Haiping. Correlations of platelet-derived growth factor and Beclin1 with vascular calcification in hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(21): 60-64. DOI: 10.7619/jcmp.20221842
|
To investigate the correlations of serum platelet-derived growth factor-BB (PDGF-BB) and autophagy-related molecule Beclin1 with vascular calcification (VC) in patients undergoing maintenance hemodialysis (MHD).
A total of 100 MHD patients were selected as MHD group, and 100 healthy people were selected as control group. The levels of serum PDGF-BB and Beclin1 were compared between the two groups. According to Abdominal Aortic Calcification Score (AACS), MHD patients were divided into calcification group (48 cases) and non-calcification group (52 cases). The influencing factors of VC in MHD patients were analyzed; the value of serum PDGF-BB and Beclin1 levels in predicting VC in MHD patients were analyzed.
The level of serum PDGF-BB in the MHD group[(90.57±31.64) pg/mL] was significantly higher than that in the control group[(41.78±13.83) pg/mL], and the level of Beclin1 in MHD group[(2.02±0.68) ng/mL] was significantly lower than that in the control group[(3.09±1.04) ng/mL] (P < 0.05). Blood phosphorus, PDGF-BB, blood calcium and TG were the risk factors for VC in MHD patients (P < 0.05), and Beclin1 was a protective factor for VC in MHD patients (P < 0.05). The area under the curve (AUC) of serum PDGF-BB and Beclin1 levels in predicting VC in MHD patients were 0.885 and 0.832, respectively; the AUC of serum PDGF-BB and Beclin1 in combination to predict VC in MHD patients was 0.932, the sensitivity was 85.4%, and the specificity was 92.3%.
The serum PDGF-BB level is higher and Beclin1 level is lower in MHD patients, both of them were related to VC. The combined prediction of serum PDGF-BB and Beclin1 may help to prevent and evaluate VC in MHD patients.
| [1] |
RAVINDRAN A, SUNNY A, KUNNATH R P, et al. Assessment of quality of life among end-stage renal disease patients undergoing maintenance hemodialysis[J]. Indian J Palliat Care, 2020, 26(1): 47-53. doi: 10.4103/IJPC.IJPC_141_19
|
| [2] |
王明莉, 陈德政. 维持性血液透析患者血清铁蛋白水平与预后的关系[J]. 临床肾脏病杂志, 2019, 19(4): 256-260. doi: 10.3969/j.issn.1671-2390.2019.04.006
|
| [3] |
陈雨, 李旻, 周华, 等. 维持性血液透析患者血清IGF-1、SOST与血管钙化的关系[J]. 山东医药, 2020, 60(25): 85-88. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY202025024.htm
|
| [4] |
ZHAO W, WANG Y, KONG W, et al. Elevated serum cartilage oligomeric matrix protein and the metalloproteinase-ADAMTS7 levels are associated with vascular calcification in maintenance hemodialysis patients[J]. Semin Dial, 2020, 33(4): 322-329. doi: 10.1111/sdi.12885
|
| [5] |
薛新月, 畅智慧, 刘兆玉. 血管平滑肌细胞在血管钙化中的调控机制研究进展[J]. 临床心血管病杂志, 2020, 36(9): 870-873. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202009020.htm
|
| [6] |
OSSAREH S, RAYATNIA M, VAHEDI M, et al. Association of serum fetuin-A with vascular calcification in hemodialysis patients and its' impact on 3-year mortality[J]. Iran J Kidney Dis, 2020, 14(6): 500-509.
|
| [7] |
李松, 陈民, 石晓娟. 通瘀煎化方配合雷公藤多苷对糖尿病肾病患者血液流变学及血清TGF-β1、PDGF-BB、CTGF的影响[J]. 世界中西医结合杂志, 2019, 14(1): 74-77, 81. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX201901026.htm
|
| [8] |
黄显元, 刘建红, 朱彦儒. α-硫辛酸对糖尿病肾病自噬相关因子LC3、Rab7和Beclin1表达的影响[J]. 中国免疫学杂志, 2019, 35(17): 2073-2078. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201917006.htm
|
| [9] |
李大勇, 袁新科, 刘冠兰, 等. 维持性血液透析患者血清Irisin、BMP-7水平与血管钙化及钙磷代谢指标的相关性研究[J]. 中国现代医学杂志, 2019, 29(15): 41-46. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXDY201915010.htm
|
| [10] |
葛均波, 徐永健. 内科学[M]. 8版. 北京: 人民卫生出版社, 2013: 459-462.
|
| [11] |
韩蓓, 韩俊岭, 曹靖昊, 等. 全段成纤维细胞生长因子23与维持性血液透析患者肾性贫血的相关性研究[J]. 实用临床医药杂志, 2021, 25(21): 114-118. doi: 10.7619/jcmp.20213812
|
| [12] |
ZBROCH E, BAZYLUK A, MALYSZKO J, et al. The serum concentration of anti-aging proteins, Sirtuin1 and αKlotho in patients with end-stage kidney disease on maintenance hemodialysis[J]. Clin Interv Aging, 2020, 15: 387-393.
|
| [13] |
李志鹏. 活动性肺结核患者外周血PDGF-BB与IP-10水平及其诊断价值[J]. 临床肺科杂志, 2019, 24(11): 2000-2003, 2019. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFK201911016.htm
|
| [14] |
LEDARD N, LIBOZ A, BLONDEAU B, et al. Slug, a cancer-related transcription factor, is involved in vascular smooth muscle cell transdifferentiation induced by platelet-derived growth factor-BB during atherosclerosis[J]. J Am Heart Assoc, 2020, 9(2): e014276.
|
| [15] |
HAN J H, PARK H S, LEE D H, et al. Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift[J]. Life Sci, 2021, 267: 118978.
|
| [16] |
邱小波, 姚丽, 盛子桐. 自噬影响慢性肾脏病血管钙化的研究进展[J]. 中国血液净化, 2018, 17(5): 321-324. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGJH201805010.htm
|
| [17] |
张晨红, 章礼久, 宋莎莎. 结直肠癌组织中自噬相关蛋白Beclin1和p62的表达特点及意义[J]. 实用医学杂志, 2020, 36(2): 206-209, 215. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202002015.htm
|
| [18] |
ZHU H W, QU Y Q. Expression levels of ARHI and Beclin1 in thyroid cancer and their relationship with clinical pathology and prognosis[J]. Oncol Lett, 2020, 19(2): 1241-1246.
|
| [19] |
QIU X B, XU Q, XU T H, et al. Metformin alleviates β-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy[J]. Exp Ther Med, 2021, 21(1): 58.
|
| [20] |
XU T H, QIU X B, SHENG Z T, et al. Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and autophagy[J]. J Cell Physiol, 2019, 234(8): 14306-14318.
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: